The Asian Scientist 100
Emi Ito
Institution
Osaka University
Country
Japan
Field
Life Sciences
Ito was awarded the 2023 JSPS Ikushi Prize by the Japan Society for the Promotion of Science for her research on unraveling the role of host-derived metabolites in the development of innate-type T cells.
(Photo: Osaka University)
AWARDS
- 2023 JSPS Ikushi Prize
Related articles
Indian Aryuvedic Plants May Hold Key To Diabetes Treatment
With the growing worldwide incidence of diabetes, a new study has revealed that traditional Aboriginal and Indian Aryuvedic plant extracts show potential for managing the disease.
Private Universities In India Can Make A Difference, But…
Private institutions can play an important role in India's higher education sector, writes Dr. Pushkar.
Antimicrobial Hydrogel To Fight Drug-Resistant Biofilms
Researchers have designed a new antimicrobial hydrogel that can break through diseased biofilms and eradicate drug-resistant bacteria upon contact.
‘Suspect’ Journals Take Scientists For A Ride
Some 'journals' are out for profit, not to carry peer-reviewed science - and researchers in the developing world are targets, reports Yojana Sharma.
OPINION: India’s Underperforming Higher Education Sector
With the exception of a handful of universities, institutes, and research centers, India's higher education institutions are of poor quality, writes Dr. Pushkar.
BMI And Life Expectancy Not Linked, Says Study
A new study says that there is little adverse association between being overweight and living longer, aside from financial costs for the community.
Million Dollar Shaw Prize Awarded For Cosmology, Immunology & Geometry
Seven scientists have won the 2011 Shaw Prize for their pioneering work on gamma ray bursts, innate immunity, and modern geometry and physics.
Inviragen Initiates Phase I Study Of Hand, Foot And Mouth Disease Vaccine
Inviragen announced this week the initiation of the first clinical trial of its Hand, Foot and Mouth Disease investigational vaccine in Singapore.
China Slashes HIV Deaths By More Than Sixty Percent
China's efforts to scale up access to highly active antiretroviral therapy over the past several years has slashed the number of HIV-related deaths by more than 60 percent.